Roca Therapeutics

First-in-Class Drugs against ocular diseases driven by hyper-vascularization and immuno-suppressive inflammation.A united team creating an innovative therapy to give a new vision to patients.

Health and bio

Latest funding

Seed · September 22, 2022

Amount not disclosed in a source on record.

Funding history ↓

Website: roca-therapeutics.org.

Category: Health and bio.

Stage: Seed.

Last round: Sep 22, 2022 · 1,512 days ago.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredApr 5, 2022 (4 years old)

Funding rounds

September 22, 2022
Seed · amount undisclosed
Source: fundraisingfox.com
April 5, 2022
Website created

Companies like Roca Therapeutics

VVandria$30.7M Series A · Aug 2024
GGranite Bio$30M Series A · Apr 2025
LLucina BiotherapeuticsSeed · Aug 2026
MModel Medicines$4.1M · Nov 2021
CCalluna Pharma$81M Series A · Jan 2024
AAMPLY Discovery$1.75M Seed · May 2025

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/roca-therapeutics (get a free API key).